Medistim ASA (0OCD) Share Price & Analysis

0 Followers

0OCD Stock Chart & Stats

kr 315.00kr 2.00(2.94%)

At close: Nov 10 4:30 PM GMT

Day’s Range: NOK 315.00 - NOK 329.00
52-Week Range: NOK 187.00 - NOK 329.00
Previous Close: NOK 306.00
Volume: N/A
Average Volume (3M): 990
Market Cap: NOK 5.72B
Enterprise Value: NOK 4.48B
Total Cash (Recent Filing): NOK 183.45M
Total Debt (Recent Filing): NOK 26.17M
Price to Earnings (P/E): 32.2
Beta: 0.23
Next Earnings: Feb 26, 2027 (Est.)
EPS Estimate: 2.43
Last Dividend Ex-Date: Oct 27, 2026
Dividend Yield: 3.30%

Medistim ASA News

Swedbank Robur Reduces Medistim Holding Below Five Percent

Medistim ASA ( ($DE:MD1) ) has shared an announcement. The release does not specify Medistim ASA’s industry, products, services or market focus. Swedbank Robur Fonder AB, through its Healthcare and

2d agoMD1 0OCD

Medistim ASA Clarifies Dividend Payment Date in Quarterly Payout

Medistim ASA ( ($DE:MD1) ) has provided an announcement. Medistim ASA’s board of directors has resolved to propose a quarterly dividend of NOK 2.50 per share, continuing its practice of

2w agoMD1 0OCD

Medistim ASA Board Proposes NOK 2.50 Quarterly Dividend

Medistim ASA ( ($DE:MD1) ) has provided an update. Medistim ASA’s board has proposed a quarterly dividend of NOK 2.50 per share, reinforcing its commitment to returning capital to shareholders

2w agoMD1 0OCD

Medistim ASA Board Proposes Quarterly Dividend of NOK 2.50 per Share

Medistim ASA ( ($DE:MD1) ) has issued an announcement. Medistim ASA’s board has proposed a quarterly dividend of NOK 2.50 per share, underscoring the company’s solid financial footing and commitment

2w agoMD1 0OCD

Medistim Sets Structured Sustainability Baseline with 2025 Report

Medistim ASA ( ($DE:MD1) ) has shared an update. Medistim ASA has released its Sustainability Report for 2025, prepared at group level in line with EFRAG’s Voluntary Sustainability Reporting Standard

2w agoMD1 0OCD

MD1 Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Medistim ASA (MD1) is scheduled to report 3rd quarter earnings on 10/23/2026. Regarding Q3 estimates, Wall Street analysts expect Medistim ASA to post earnings of NOK2.06 per share. Revenue expectations

3w agoMD1 0OCD

Medistim Schedules Webinar for Q3 2026 Results and Company Update

The latest announcement is out from Medistim ASA ( ($DE:MD1) ). Medistim ASA will present its third-quarter 2026 results and financials, along with an update on the company’s status, in

3w agoMD1 0OCD

Medistim Publishes Protocol from Extraordinary General Meeting

Medistim ASA ( ($DE:MD1) ) has provided an update. Medistim ASA has released the official protocol from its extraordinary general meeting held on 5 October 2026, providing shareholders with a

1M agoMD1 0OCD

Medistim Chairman Secures Voting Control Over More Than 22% of Shares for Extraordinary Meeting

Medistim ASA ( ($DE:MD1) ) has shared an update. Medistim ASA has disclosed that its chairman, Øyvin Brøymer, has received authorization to vote a total of 1,816,954 shares at the

1M agoMD1 0OCD

Medistim Calls Extraordinary General Meeting to Engage Shareholders

Medistim ASA ( ($DE:MD1) ) has issued an update. Medistim ASA has called an extraordinary general meeting to be held on 5 October 2026 at its Oslo headquarters, inviting shareholders

1M agoMD1 0OCD

0OCD FAQ

What was Medistim ASA’s price range in the past 12 months?

Medistim ASA lowest share price was kr 187.00 and its highest was kr 329.00 in the past 12 months.

What is Medistim ASA’s market cap?

Medistim ASA’s market cap is kr 5.72B.

When is Medistim ASA’s upcoming earnings report date?

Medistim ASA’s next earnings report is estimated for Feb 26, 2027 (not yet confirmed), which is in 107 days.

How were Medistim ASA’s earnings last quarter?

Medistim ASA released its earnings results on Oct 23, 2026. The company reported kr 2.61 earnings per share for the quarter, beating the consensus estimate of kr 2.06 by kr 0.55.

Is Medistim ASA overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Medistim ASA pay dividends?

Medistim ASA pays an annual dividend of kr 2.5 which represents an annual dividend yield of 3.3%. See more information on Medistim ASA dividends here

What is Medistim ASA’s EPS estimate?

Medistim ASA’s EPS estimate is 2.43.

How many shares outstanding does Medistim ASA have?

Medistim ASA has 18,337,336 shares outstanding.

What happened to Medistim ASA’s price movement after its last earnings report?

Medistim ASA reported an EPS of kr 2.61 in its last earnings report, beating expectations of kr 2.06. Following the earnings report the stock price went up 5.634%.

Which hedge fund is a major shareholder of Medistim ASA?

Currently, no hedge funds are holding shares in GB:0OCD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Medistim ASA

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.

Medistim ASA (0OCD) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	15	3	4
Technical Analysis	3	3	4
Moving Averages	12	0	0

Technical Analysis >

Similar Stocks

Stocks similar to GB:0OCD
Company	Price & Change	Follow
DE:MD1Medistim ASA
DE:LIFTempest Minerals Limited

Compare GB:0OCD Stocks >

Ownership Overview

3.45% Mutual Funds
96.43% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

0OCD Stock Chart & Stats

Medistim ASA News

Swedbank Robur Reduces Medistim Holding Below Five Percent

Medistim ASA Clarifies Dividend Payment Date in Quarterly Payout

Medistim ASA Board Proposes NOK 2.50 Quarterly Dividend

Medistim ASA Board Proposes Quarterly Dividend of NOK 2.50 per Share

Medistim Sets Structured Sustainability Baseline with 2025 Report

MD1 Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Medistim Schedules Webinar for Q3 2026 Results and Company Update

Medistim Publishes Protocol from Extraordinary General Meeting

Medistim Chairman Secures Voting Control Over More Than 22% of Shares for Extraordinary Meeting

Medistim Calls Extraordinary General Meeting to Engage Shareholders

0OCD FAQ

Company Description

Medistim ASA

Medistim ASA (0OCD) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Ownership Overview

Popular Stocks

Become an Expert with TipRanks Premium